Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial
Published Online: 2016-01-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Axel Hinke•Christina Balser•Christoph Losem•Eckhart Weidmann•Frank Kauff•Hans-Peter Boeck•Juergen Barth•Julia Vereshchagina•Lars Hahn•Lothar Mueller•Manfred Welslau•Martina Stauch•Mathias Rummel•Michael Sandherr•Norbert Niederle•Ulrich Kaiser•Ulrich von Gruenhagen•Wolfgang Blau•Wolfram Brugger
